Abstract
Background:Antidepressants, benzodiazapines, and opioid medications are used to manage the pain, anxiety, or depression associated with workplace injuries.Objective:To evaluate the impact of these medications on workers' compensation costs and time lost from work.Methods:A cohort of 22,383 indemnity claims from 2008 to 2013 were evaluated for the association of prescribed medications on claim cost and delayed claim closure controlling for confounders.Results:Claims with anti-depressant, opioid, or benzodiazepine prescriptions were 2.24 (95% CI: 2.00 to 2.51), 1.14 (95% CI: 1.02 to 1.27), and 1.38 (95% CI: 1.23 to 1.54) times more likely to remain open at the end of the study.Conclusion:The concurrent treatment of pain, depression or anxiety, and occupational injuries are associated with large increases in claim cost and delayed return to work.
Original language | English (US) |
---|---|
Pages (from-to) | E206-E211 |
Journal | Journal of occupational and environmental medicine |
Volume | 61 |
Issue number | 5 |
DOIs | |
State | Published - May 1 2019 |
Keywords
- Anti-depressant
- Benzodiazepines
- Occupational injury
- Opioid
- Psychotropic mediation
- Workers' compensation
ASJC Scopus subject areas
- Public Health, Environmental and Occupational Health